ODAN-PROCHLORPERAZINE 10 MG — DIN 00789720
PROCHLORPERAZINE : 10 MG · ODAN LABORATORIES LTD · SUPPOSITORY · wholesale supply in Canada
Health Canada status: MARKETED
What is ODAN-PROCHLORPERAZINE?
ODAN-PROCHLORPERAZINE 10 MG contains PROCHLORPERAZINE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 00789720, held by ODAN LABORATORIES LTD, supplied as SUPPOSITORY for RECTAL administration. Health Canada currently lists it as marketed, status dated 18-Nov-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ODAN-PROCHLORPERAZINE used for?
In the management of manifestations of psychotic disorders such as agitation, confusion, delusion, tension and anxiety. Prochlorperazine is also effective in controlling nausea and vomiting due to stimulation of the chemoreceptor trigger zone (CTZ). In selected patients, prochlorperazine may be of value for the relief of excessive anxiety, accompanied by severe tension and agitation, associated with psychoneurotic or somatic conditions.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Is there a generic Prochlorperazine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
7 holders have a Canadian DIN containing Prochlorperazine, across 15 DINs, of which 3 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AA PHARMA INC | 2 | 2 | PROCHLORAZINE | Sourceable in Canada |
| ODAN LABORATORIES LTD | 1 | 1 | ODAN-PROCHLORPERAZINE | Sourceable in Canada |
| PHARMASCIENCE INC | 4 | 0 | PMS PROCHLORPERAZINE INJ 5MG/ML, PMS-PROCHLORPERAZINE SUPPOSITOIRES 10MG, PMS-PROCHLORPERAZINE TAB 10MG, PMS-PROCHLORPERAZINE TAB 5MG | No marketed DIN |
| AVENTIS PHARMA INC | 3 | 0 | STEMETIL LIQ 5MG/5ML, STEMETIL TAB 10MG, STEMETIL TAB 5MG | No marketed DIN |
| NU-PHARM INC | 2 | 0 | NU-PROCHLOR TAB 10MG, NU-PROCHLOR TAB 5MG | No marketed DIN |
| SANOFI-AVENTIS CANADA INC | 2 | 0 | STEMETIL | No marketed DIN |
| SANDOZ CANADA INCORPORATED | 1 | 0 | PROCHLORPERAZINE MESYLATE INJ 5MG/ML | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 10 MG |
|---|---|
| Dosage form | SUPPOSITORY |
| Route | RECTAL |
| Pack configuration (monograph) | Boxes of 10 suppositories |
| Storage | Store below 25°C. Protect unwrapped suppository from light. Keep out of reach and sight of children. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Prochlorperazine |
|---|---|
| ATC code | N05AB04 |
| AHFS class | 28:16.08.24 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00789720 |
|---|---|
| DIN (unpadded, as printed on some documents) | 789720 |
| Brand name | ODAN-PROCHLORPERAZINE |
| Generic / active ingredient | PROCHLORPERAZINE : 10 MG |
| Market authorization holder | ODAN LABORATORIES LTD |
| Health Canada schedule | Prescription |
| ATC code | N05AB04 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05AB |
| Current status | MARKETED |
| Status date | 18-Nov-2024 |
| Original market date | 1989-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults: 1 suppository 1-3 times daily for nausea/anxiety. Psychiatry: Start 10 mg 3-4 times daily, adjust gradually. Use lowest effective dose for maintenance.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Circulatory collapse, comatose states, drug intoxication, blood dyscrasias, liver disease, renal insufficiency, pheochromocytoma, severe cardiovascular disorders, subcortical brain damage.
Warnings and precautions
May mask signs of drug overdose or brain tumors. Risk of Neutropenia/Agranulocytosis (monitor CBC). May impair mental/physical abilities for driving. Risk of Venous Thromboembolism.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
3 of 15 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| PROCHLORAZINE | 5 MG | TABLET | AA PHARMA INC | MARKETED | 00886440 |
| PROCHLORAZINE | 10 MG | TABLET | AA PHARMA INC | MARKETED | 00886432 |
| NU-PROCHLOR TAB 10MG | 10 MG | TABLET | NU-PHARM INC | CANCELLED POST MARKET | 01964402 |
| NU-PROCHLOR TAB 5MG | 5 MG | TABLET | NU-PHARM INC | CANCELLED POST MARKET | 01964399 |
| PMS PROCHLORPERAZINE INJ 5MG/ML | 5 MG | SOLUTION | PHARMASCIENCE INC | CANCELLED POST MARKET | 00753645 |
| PMS-PROCHLORPERAZINE SUPPOSITOIRES 10MG | 10 MG | SUPPOSITORY | PHARMASCIENCE INC | CANCELLED POST MARKET | 00753688 |
| PMS-PROCHLORPERAZINE TAB 10MG | 10 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | 00753637 |
| PMS-PROCHLORPERAZINE TAB 5MG | 5 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | 00753661 |
| PROCHLORPERAZINE MESYLATE INJ 5MG/ML | 5 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | 00789747 |
| STEMETIL | 10 MG | SUPPOSITORY | SANOFI-AVENTIS CANADA INC | CANCELLED POST MARKET | 01927795 |
2 · Same class — other molecules in ATC N05AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Perphenazine | PERPHENAZINE · PERPHENAZINE 16 TAB · PERPHENAZINE 2 TAB 2MG · PERPHENAZINE 8 TAB 8MG · +17 more | 25 | 4 | Yes |
| Fluphenazine | APO FLUPHENAZINE TAB 2.5MG · APO-FLUPHENAZINE INJECTABLE · FLUPHENAZINE · FLUPHENAZINE 1 TAB 1MG · +17 more | 25 | 3 | Yes |
| Prochlorperazine | NU-PROCHLOR TAB 10MG · NU-PROCHLOR TAB 5MG · ODAN-PROCHLORPERAZINE · PMS PROCHLORPERAZINE INJ 5MG/ML · +9 more | 15 | 3 | Yes |
| Trifluoperazine | NOVO-FLURAZINE TAB 1MG · NOVO-FLURAZINE TAB 20MG · NOVO-TRIFLUZINE - TAB 10MG · NOVO-TRIFLUZINE - TAB 2MG · +26 more | 38 | 0 | Not in Canada |
| Thioproperazine | MAJEPTIL | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N05A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N05AH | Asenapine · Clozapine · Loxapine · Olanzapine · Quetiapine | 589 | 220 |
| N05AX | Aripiprazole · Brexpiprazole · Cariprazine · Paliperidone · Risperidone | 352 | 175 |
| N05AE | Lurasidone · Ziprasidone | 60 | 41 |
| N05AD | Droperidol · Haloperidol | 53 | 9 |
| N05AF | Flupentixol · Tiotixene · Zuclopenthixol | 25 | 8 |
| N05AA | Chlorpromazine · Levomepromazine · Promazine | 51 | 8 |
| N05AN | Lithium | 26 | 7 |
| N05AC | Mesoridazine · Periciazine · Pipotiazine · Thioridazine | 32 | 3 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is ODAN-PROCHLORPERAZINE called?
The same molecule, Prochlorperazine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Stemetil | Latin | Norway |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Prochlorperazine called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Prochlorperazine, published to help those searches reach this page.
| Language | Prochlorperazine |
|---|---|
| Arabic العربية | بروكْلوربيرازين |
| Russian Русский | прохлорперазин |
| Spanish Español | Proclorperazina |
| French Français | Prochlorpérazine |
| Portuguese Português | Proclorperazina |
| German Deutsch | Prochlorperazin |
| Japanese 日本語 | プロクロルペラジン |
| Korean 한국어 | 프로클로르페라진 |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.